cid:image001.jpg@01D158FE.B69B8D00
cid:image003.jpg@01D5994E.D962B040
Hello everyone,
I have a very unique outreach opportunity to share with you! The Royal Manitoba Theatre Centre has asked if one of our members would be willing to write a short article (350 words) related to mental health and gratitude (this could extend to the practice of mindfulness as well). The article will be included in the program for an upcoming play that will be staged in January. Additional details are provided in the forwarded email below. If you are interested, please contact me ASAP as this is somewhat time-sensitive. As you will see, it includes a nice little perk too!
Best wishes, Sari
Sari S. Hannila, PhD
Director of Outreach, Manitoba Neuroscience Network
Associate Professor, Department of Human Anatomy and Cell Science
Rady Faculty of Health Sciences, University of Manitoba
cid:image003.jpg@01D5994E.D962B040
cid:image004.jpg@01D158FE.B69B8D00
Begin forwarded message:
From: Kathleen Cerrer <kcerrer(a)royalmtc.ca>
Date: Nov. 12, 2019 at 10:43 a.m.
To: info <info(a)manitobaneuroscience.ca>
Subject: Manitoba Neuroscience Network in Royal MTC Program
Good morning,
I’m writing from the Royal Manitoba Theatre Centre. In January, we are presenting a show called “Every Brilliant Thing” which focuses on mental health and the power of gratitude for physical and mental healing.
We’d like to include an article in our program about the power of gratitude and the scientific evidence behind it. Might there be someone at the Manitoba Neuroscience Network that could contribute to our program? The piece would be approximately 350 words and the deadline is Thurs, Nov 28. We would be happy to give you a pair of tickets to the show.
Show information https://royalmtc.ca/Current-Plays/Every-Brilliant-Thing.aspx
Please let me know if you have any questions.
Many thanks,
Kathleen
Kathleen Cerrer, Publicist
ROYAL MANITOBA THEATRE CENTRE
Box Office 204 942 6537 | 1 877 446 4500
ROYALMTC.CA | WINNIPEGFRINGE.COM
/sent on behalf of
Benedict C. Albensi, PhD, BCMAS, CRQM
Professor & Manitoba Dementia Research Chair
Dept. of Pharmacology & Therapeutics
Biomedical Engineering Core Member
Faculties of Health Sciences, Engineering, & Science
Research Affiliate, Centre on Aging
Principal Investigator & Everett Endowment Fund Chair (Alzheimer's research)
St. Boniface Hospital Research
S E M I N A R & V I S I T I N G S P E A K E R S E R I E S
D AT E
Wednesday, November 13, 2019
12:00 PM (Noon)
*** Followed by a trainee lunch in SR415 Kleysen Institute for Advanced
Medicine , Boardroom
LO C AT I O N
BMSB, Theatre C, Bannatyne Campus
S P E A K E R
Alyson Fournier, PhD
Professor
Faculty of Medicine
McGill University
T O P I C
Small molecule stabilization of protein interactions to promote axon
regeneration
A B S T R A C T
Damaged central nervous system (CNS) neurons have a poor ability to
spontaneously regenerate, causing persistent functional deficits after
injury. Therapies that stimulate axon growth are needed to repair CNS
damage.
14-3-3 adaptors are hub proteins that are attractive targets to manipulate
cell signaling. We have identified a positive role for 14-3-3s in axon
growth and have shown that fusicoccin-A (FC-A), a small-molecule stabilizer
of 14-3-3 protein-protein interactions, stimulates axon growth in vitro and
regeneration in vivo. Further screening of FC-A derivatives has revealed
potent axon growth-promoting compounds. Through mass spectrometry, we find
that FC-A and a potent derivative, stabilize interactions between 14-3-3
proteins and multiple components of the Rap1 pathway to facilitate axon
growth. Thus, FC-A and its derivatives exhibit remarkable polypharmacology
facilitating axon regeneration. These findings show that 14-3-3 adaptor
protein complexes are druggable targets and identify a new class of small
molecules that may be further optimized for the repair of CNS damage.
O B J E C T I V E S
1. Define 14-3-3- adaptor proteins and small molecules targeting these
proteins
2. Describe the influence of small molecules targeting 14-3-3 proteins on
axon regeneration in a pre-clinical optic nerve injury model
3. Discuss the mechanism used by these small molecules to promote axon
regeneration
B I O
Dr. Alyson Fournier (PhD) is a Professor in the Faculty of Medicine at
McGill University in Montreal, Canada. She completed her Ph.D. in
Neuroscience at McGill University (1998) and conducted her postdoctoral
training at Yale University with Dr. Strittmatter working on
neurodevelopment and regeneration. Since 2003 Dr. Fournier has led a
research lab at the Montreal Neurological Institute studying molecular
mechanisms
regulating axon degeneration and regeneration. Dr. Fourniers group studies
neuronal signaling in response to acute nerve cell injury and inflammation
for the conception and validation of new therapeutic targets to
promote neuroprotection and repair.
Tabrez Sidddiqui
Chair, MNN Visiting Speaker & Seminar Series
Tabrez.siddiqui(a)umanitoba.ca <mailto:Tabrez.siddiqui@umanitoba.ca>
Kelly Jorundson
Executive Assistant
Manitoba Neuroscience Network
Email: kjorund(a)sbrc.ca <mailto:kjorund@sbrc.ca>
Tel: 204.235.3939 Fax: 204.237.4092
St. Boniface Hospital Albrechtsen Research Centre
Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA
******************************************
<http://www.manitobaneuroscience.ca/>
<https://www.facebook.com/manitobaneuroscience/?fref=ts>
<https://www.instagram.com/manitobaneuroscience/>
<https://twitter.com/manitobaneuro>